Logo

Suggestions

  • Cancer Disparities
  • Opinion
  • Conferences
  • News
  • Patient Corner
  • About
    • Contact
    • Article Submission
  • Top Headlines
    • Cancer Types
      • Breast Cancer
      • Cervical Cancer
      • GI Malignancies
      • Melanoma & Skin Cancer
      • GU Malignancies
      • Gynecologic Oncology
      • Hematologic Malignancies
      • Lung Cancer
  • Expert Opinion
  • Video News
  • New Approvals
  • Cancer Disparities
  • Patient Corner
  • Subscribe

Logo

Tara Shah

Conference Coverage/Lung Cancer/Opinion

My Take On KEYNOTE-671: ASCO23 June 3, 2023

Author:  Lei Deng, MD PGY-6 Fellow of Hematology/Oncology – Roswell Park Comprehensive Cancer Center, Buffalo, NY.  Incoming Assistant Professor at UW/Fred Hutch, Seattle, WA Live report from ASCO23, Chicago, IL June 3, 2023  8am

Lei Deng
Conference 2023/Conference Coverage/Opinion

Updates from ASCO23 – ADAURA Trial Plenary Lecture

Author:  Lei Deng, MD PGY-6 Fellow Of Hematology/Oncology – Roswell Park Comprehensive Cancer Center, Buffalo, NY.  Incoming Assistant Professor At UW/Fred Hutch, Seattle, WA   Live report from ASCO23, Chicago, IL June 4, 2023   Overall survival analysis from the ADAURA trial

June 4, 2023

FDA Approves Luspatercept-aamt for Anemia in Patients with Myelodysplastic Syndromes

News

On August 28, 2023, the U.S. Food and Drug Administration approved luspatercept-aamt (Reblozyl) for the treatment of anemia in adult patients with very low- to intermediate-risk

FDA_Approved
News

FDA Approves Luspatercept-aamt for Anemia in Patients with Myelodysplastic Syndromes

On August 28, 2023, the U.S. Food and Drug Administration approved luspatercept-aamt (Reblozyl) for the treatment of anemia in adult patients with very low- to intermediate-risk myelodysplastic syndromes (MDS) without prior erythropoiesis-stimulating agent (ESA) use,

More
by Tara Shah
September 20, 2023
Lei Deng
Conference 2023/Conference Coverage/Opinion

Updates from ASCO23 – ADAURA Trial Plenary Lecture

Author:  Lei Deng, MD PGY-6 Fellow Of Hematology/Oncology – Roswell Park Comprehensive Cancer Center, Buffalo, NY.  Incoming Assistant Professor At UW/Fred Hutch, Seattle, WA   Live report from ASCO23, Chicago, IL June 4, 2023

More
by Tara Shah
June 4, 2023
Conference Coverage/Lung Cancer/Opinion

My Take On KEYNOTE-671: ASCO23 June 3, 2023

Author:  Lei Deng, MD PGY-6 Fellow of Hematology/Oncology – Roswell Park Comprehensive Cancer Center, Buffalo, NY.  Incoming Assistant Professor at UW/Fred Hutch, Seattle, WA Live report from ASCO23, Chicago, IL June 3, 2023  8am

More
by Tara Shah

your advertisement here

you may also like...

  • FDA_Approved
    FDA Approves Luspatercept-aamt for Anemia in Patients with Myelodysplastic Syndromes
  • Overview of KEYNOTE-671 & NADIM II
  • Expert Opinion: Children’s Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse
  • FDA_Approved
    FDA Approves HEPZATO KIT for Uveal Melanoma with Unresectable Hepatic Metastases
  • FDA_Approved
    FDA Approves Elranatamab-bcmm for Multiple Myeloma with Relapsed or Refractory Status

All Categories

  • Awareness
  • Breast Cancer
  • Cancer Disparities
  • Cancer Research
  • Conference 2023
  • Conference Coverage
  • Conferences
  • Events
  • GI Malignancies
  • GU Malignancies
  • Hematologic Malignancies
  • Journal
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Nepal Cancer Center
  • New Approvals
  • New Drug Applications
  • News
  • Opinion
  • Patient Corner
  • Spotlights
  • Uncategorized
  • Updates
  • Video News
  • Volunteer Spotlight

Search By Keyword

ASCO ASCO23 award Binaytara foundation breast cancer BTF cancer cancer care cancer disparities cancer research cancer survival cancer treatment Cellular therapy CME conference Conferences continuing education Dr. Binay Shah Dr Anish Shah Dr Shipra Gandhi Expert Opinion faculty highlight FDA FDA Approval FDA approved head & neck cancer surgery in Nepal healthcare equity hematological malignancies hematologic malignancies leukemia Lung cancer lymphoma multiple myeloma Nepal cancer care oncology CME SCHD video news Volunteer

We Transform Cancer Care

Dissect complex information on cancer and disseminate knowledge to healthcare professionals, patients, and caregivers. We want to improve patient outcomes.
Cover the latest research to promote precision oncology and patient-centered care.
Questions? Contact us -
[email protected]

Social Media

Advertisement


Footer Logo
  • Facebook
  • Twitter
  • LinkedIn

© 2023 - All Rights Reserved. Binaytara Foundation

  • About
  • Submit an Article
  • Subscribe for updates
  • Editorial Board
  • Privacy Policy
  • Contact
  • Home
  • Top Headlines
    • Awareness
    • Video News
    • Cancer Types
      • Breast Cancer
      • Cervical Cancer
      • Melanoma & Skin Cancer
      • GI Malignancies
      • Lung Cancer
      • Hematologic Malignancies
      • Gynecologic Oncology
      • GU Malignancies
  • New in Cancer Care
  • Conferences
    • Hemotology & Oncology Conference Calendar
    • Conference Calendar
    • Conference Coverage
  • New Approvals
  • Contact us
  • Submit an article